Research article · 15 Apr 2026
Conference abstractPublished 20 Aug 2012
Complexity of differentiating cerebral-renal salt wasting from SIADH, emerging importance of determining fractional urate excretion
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
C erebral salt wasting (CSW), or the preferred and more appropriate term, renal salt wasting (RSW), continues to be an ill-defined syndrome that requires clarification. Presently, there is general agreement that RSW does exist, but there is disagreement over its prevalence, generally considered to be common among neurosurgeons and SIADH to be more common than RSW among internists. This difference in estimating the prevalence of both disorders defines how difficult it is to differentiate RSW from SIADH. Resolution of this discrepancy becomes vital because of divergent therapeutic goals for both syndromes, to administer salt and water to volume-depleted patients with RSW and to water-restrict water-loaded patients with SIADH. The awareness that even mild hyponatremia induces symptoms with potentially serious consequences has led to a tendency to treat all hyponatremic patients, thus introducing a therapeutic urgency to differentiate RSW from SIADH. To add further uncertainty to this diagnostic and therapeutic dilemma are the recent reports of RSW occurring in patients without clinical cerebral disease.. The approach to the diagnosis and treatment of hyponatremia can thus be considered to be in a state of flux. We intend to discuss: 1. why it is so difficult to differentiate RSW from SIADH, 2. present data to confirm RSW to be much more common than SIADH in neurosurgical patients, 3. an updated definition of RSW, 4. review how determination of fractional excretion (FE) of urate can play a pivotal role in evaluating patients with hyponatremia, emphasizing how a previously increased FEurate will normalize to 4-11% in SIADH and remain persistently increased in RSW after correction of hyponatremia by water-restriction or hypertonic saline, 5. present data to support our contention that an increased FEurate with normonatremia without correction of previous hyponatremia is consistent with RSW, 6. a normal FEurate with hyponatremia in a nonedematous patient is highly suggestive of reset osmostat, 7. present a new algorithm to approaching patients with hyponatremia , 8. demonstrate natriuretic activity in plasma of patients with RSW, 9. Present data on RSW occurring in patients without cerebral disease, 10. briefly review treatment modalities in RSW 11. propose changing CSW to RSW and 12. suggest eliminating reset osmostat as a subtype of SIADH because of normal FEurate and predictability of ADH response to changes in plasma osmolality.
Subjects
Nephrology & UrologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Nephrology & Therapeutics.
Brief report · 30 Mar 2026
Renal Fibrosis: Targeting Pathways For New Therapies
Brief report · 30 Mar 2026
SGLT2 Inhibitors: A New Era for Diabetic Kidney Disease
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Nephrology & Therapeutics
- SubjectNephrology & Urology
- BylineArticles whose byline prints “John K. Maesaka”
